Pymedix is building fully automated machine perception technologies that move the radiotherapy experience forward. With never-before-seen accuracy and speed, our 3D deformable image registration software, Autofuse, makes better, more personalized cancer treatment possible. We have the cross-disciplinary expertise needed to translate ideas from different fields, to combine them in innovative ways, and to implement solutions that bridge the gaps between research, engineering, and medicine. Our technology will keep radiotherapy at the forefront of personalized medicine and big data while making planning workflow as intelligent and efficient as possible for physicians, dosimetrists, and physicists. The mission of Pymedix is to build medical artificial intelligence by combining the strengths of human and digital intelligence. Our vision is to build the future of medicine for all by transforming, accelerating, and optimizing healthcare through artificial intelligence.
Total Funding: $290 K
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2018
